For a healthier world that is hepatitis free

First launched in 2021 to support local communities in strengthening liver disease education across Asia Pacific, the Gilead ALL4LIVER Grant expanded its coverage globally (outside of the US) in 2023.

Striving for global viral hepatitis elimination by 2030

With 2030 fast approaching, the All4Liver Grant aims to empower communities to accelerate initiatives to end viral hepatitis as a public health threat.

TEST

driving tests for viral hepatitis

Link

SUPPORTING LINKAGE TO CARE FOR PEOPLE AFFECTED BY VIRAL HEPATITIS

Prioritize

Putting viral hepatitis (back) on the public health agenda

In 2023, the Grant received
submissions from 146 organizations
around the world.

Out of 146 applications, we provided funding support to 71 projects across 33 geographies to address unmet needs and underserved key populations.

Addressing gaps in HBV, HCV and HDV

>50%

of funded projects focus on either HBV or HCV

~20%

of funded projects address 2 types of hepatitis or more

7%

of funded projects aims to address gaps in HBV, HCV and HDV

Closing gaps through
Test and Link

of funded projects address gaps in testing

of funded projects address gaps in linkage to care for people living with viral hepatitis

of funded projects put viral hepatitis back on the public health agenda

LET’S CONTINUE WORKING TOGETHER TO CREATE A WORLD WHERE HEALTH IS EQUITABLE, ACCESSIBLE, AND FREE FROM VIRAL HEPATITIS.